216 related articles for article (PubMed ID: 2649954)
1. [Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism].
Moser U; Waldburger M; Schwarz HA; Gobelet CA
Schweiz Rundsch Med Prax; 1989 Mar; 78(10):263-9. PubMed ID: 2649954
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomised multicentre study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulant patients with osteoarthritis and extra-articular rheumatism.
Moser U; Waldburger H; Schwarz HA; Gobelet CA
Scand J Rheumatol Suppl; 1989; 80():71-80. PubMed ID: 2688081
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experiences with tenoxicam. Preliminary results of a multicenter study].
Marcolongo R; Fioravanti A
Recenti Prog Med; 1991 Apr; 82(4):242-9. PubMed ID: 1857847
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of tenoxicam--an overview.
Vischer TL
Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
[TBL] [Abstract][Full Text] [Related]
5. A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.
Bellamy N; Buchanan WW; Chalmers A; Ford PM; Kean WF; Kraag GR; Gerecz-Simon E; Campbell J
J Rheumatol; 1993 Jun; 20(6):999-1004. PubMed ID: 8350339
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of tenoxicam--an overview.
Vischer TL
Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
Perpignano G; Bogliolo A; Puccetti L
Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
[TBL] [Abstract][Full Text] [Related]
8. A large multicentre, parallel group, double-blind study comparing tenoxicam and piroxicam in the treatment of osteoarthritis and rheumatoid arthritis.
Simpson J; Golding DN; Freeman AM; Cooke D; Hooper PA; Jamieson V; Osborne C
Br J Clin Pract; 1989 Sep; 43(9):328-33. PubMed ID: 2695152
[TBL] [Abstract][Full Text] [Related]
9. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
Bird HA; Hill J; Dixon JS; Looi D; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
[TBL] [Abstract][Full Text] [Related]
10. Tenoxicam or diclofenac in the treatment of gonarthrosis.
Chahade WH; Marques GC
Eur J Rheumatol Inflamm; 1987; 9(2):77-80. PubMed ID: 3329113
[No Abstract] [Full Text] [Related]
11. A randomized, double-blind study to compare tenoxicam with sustained release indomethacin in osteoarthritic patients treated in general practice.
Hooper PA; O'Brien K; Spence S
J Int Med Res; 1989; 17(1):17-23. PubMed ID: 2651174
[TBL] [Abstract][Full Text] [Related]
12. Tenoxicam in soft-tissue rheumatism.
Schorn D
S Afr Med J; 1986 Mar; 69(5):301-3. PubMed ID: 3515589
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tenoxicam in rheumatology--clinical trial results in Argentina and Brazil.
Barclay CA; Traballi CA
Eur J Rheumatol Inflamm; 1987; 9(2):26-50. PubMed ID: 3329108
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
Porzio F
Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
[TBL] [Abstract][Full Text] [Related]
15. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Gonzalez JP; Todd PA
Drugs; 1987 Sep; 34(3):289-310. PubMed ID: 3315620
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
Kidd B; Frenzel W
J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
[TBL] [Abstract][Full Text] [Related]
17. Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints.
Adelowo OO; Chukwuani CM; Grange JJ; Ojeasebhulo EE; Onabowale BO
West Afr J Med; 1998; 17(3):194-8. PubMed ID: 9814091
[TBL] [Abstract][Full Text] [Related]
18. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
Fiszman P; Perpétuo JB; Sidi A
Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
[TBL] [Abstract][Full Text] [Related]
19. A long-term randomised trial on tenoxicam and piroxicam in osteoarthritis of the hip or knee: a 24-month interim report focusing on the 12-24 month interval.
Lund B; Andersen RB; Fossgreen J; Holm P; Jensen EM; Kirchheiner B; Kryger J; Pichard J
Eur J Rheumatol Inflamm; 1987; 9(2):58-67. PubMed ID: 3329110
[TBL] [Abstract][Full Text] [Related]
20. [Tenoxicam, a new long-acting non-steroidal anti-inflammatory drug. A placebo-controlled multicenter study].
Gallo C; Vighi G; Schroeder J
Clin Ter; 1987 Mar; 120(5):405-14. PubMed ID: 2953540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
